Concurrent chemoradiotherapy with S-1 versus platinum in the treatment of locoregionally advanced nasopharyngeal carcinoma: a multicenter, retrospective, propensity score-matched analysis
The results suggest that S-1 can be used as a concurrent chemotherapy regimen during radiotherapy for patients with LANPC, since it presents a noninferior survival benefit compared with platinum and shows tolerable adverse effects.
Authors
- Chenbin Bian
- Qin Zhao (ORCID: https://orcid.org/0000-0002-7442-5162)
- Xin Jiang (ORCID: https://orcid.org/0000-0002-4613-7438)
- Jing Su (ORCID: https://orcid.org/0009-0007-9636-1714)
- Sitong Chang
- Zhuangzhuang Zheng (ORCID: https://orcid.org/0000-0001-7683-4480)
- Huiyuan Yu (ORCID: https://orcid.org/0000-0002-3991-4788)
- Jindian Bao
Institutions
- Jilin University (CN)
- First Hospital of Jilin University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-06
- DOI
- https://doi.org/10.3389/fphar.2024.1394754
- Citations
- 1
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.58
Funders
- Jilin University
- Department of Science and Technology of Jilin Province